A molecular survey of phenylketonuria in Iceland: Identification of a founding mutation and evidence of predominant Norse settlement

European Journal of Human Genetics

Volumn 5, Issue 6, 1997, Pages 376-381

  Guldberg, Per ^a   Zschocke, Johannes ^b   Dagbjartsson, Atli ^c   Henriksen, Karen Friis ^a   Güttler, Flemming ^a  

^a JOHN F KENNEDY INSTITUTE   (Denmark)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Founder effect; Founder mutation; Iceland; Norway; Phenylalanine hydroxylase; Phenylketonuria

Indexed keywords

PHENYLALANINE 4 MONOOXYGENASE;

ANTHROPOLOGY; ARTICLE; CLINICAL ARTICLE; FOUNDER EFFECT; GENE MUTATION; GENE POOL; HAPLOTYPE; HUMAN; ICELAND; MALE; PHENYLKETONURIA; POPULATION GENETICS; PRIORITY JOURNAL;

EID: 0031456266     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1159/000484795     Document Type: Article

References (30)

1. Scriver CR, Kaufman S, Eisensmith RC, Woo SLC: The hyperphenylalaninemias; in Scriver Cr, Beaudet AL, Sly WS, Valle D (eds): The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, 1995, pp 1015-1075.
2. Eisensmith RC, Woo SLC: population genetics of phenylketonuria. Acta Paediatr Suppl 1994; 407:19-26.
3. Lyonnet S, Melle D, de Braekeleer M, Larramboise R, Rey F, John SWM, Berthelon M, Berthelot J, Journel H, Le Marec B, Parent P, de Parscau L, Saudubray JM, Rozen R, Rey J, Munnich A, Scriver CR: Time and space clusters of the French-Canadian M1V phenylketonuria mutation in France. Am J Hum Genet 1992;51:191-196.
4. Treacy E, Byck S, Clow C, Seirver CR: 'Celtic' phenylketonuria mutations found? Evidence in two regions of Quebec province. Eur J Hum Genet 1993;1:220-228.
5. Ramus SJ, Treacy EP, Cotton RG: Characterization of phenylalanine hydroxylase alleles in untreated phenylketonuria patients from Victoria, Australia: Origin of alleles and haplotypes. Am J Hum Genet 1995;56:1034-1041.
6. Eiken HG, Knappskog PM, Boman H, Thune KS, Kaada G, Motzfeld K, Apold J: Relative frequency, heterogeneity and geographic clustering of PKU mutations in Norway. Eur J Hum Genet 1996;4:205-213.
7. Avigad S, Cohen BE, Bauer S, Schwartz G, Frydman M, Woo SLC, Niny Y, Shiloh Y: A single origin of phenylketonuria in Yemenite Jews. Nature 1990;344:168-170.
8. Magnusson SA: Northern Sphinx. Iceland and Icelanders from the settlement to the present. London, Hurst, 1977.
9. Nordal J, Kristinsson V: Iceland 874-1974. Reykjavik, The Central Bank of Iceland, 1975.
10. Williams JT: Origin and population structure of the Icelanders. Hum Biol 1993;65:167-191.
11. Eisensmith RC, Woo SLC: Updated listing of haplotypes at the human phenylalanine hydroxylase (PAH) locus. Am J Hum Genet 1992;51:1445-1448.
12. Goltsov AA, Eisensmith RC, Naughton ER, Jin L, Chakraborty R, Woo SL: A single polymorphic STR system in the human phenylalanine hydroxylase gene permits rapid prenatal diagnosis and carrier screening for phenylketonuria. Hum Mol Genet 1993;2:577-581.
13. Goltsov AA, Eisensmith RC, Konecki DS, Lichter-Konecki U, Woo SLC: Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene. Am J Hum Genet 1992;51:627-636.
14. Güttler F: Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency. Acta Paedriatr Scand Suppl 1980;280:1-80.
15. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
16. Guldberg P, Güttler F: 'Broad-range' DGGE for single-step mutation scanning of entire genes: Application to human phenylalanine hydroxylase gene. Nucleic Acids Res 1994;22: 880-881.
17. Guldberg P, Romano V, Ceratto N, Bosco P, Ciuna M, Indelicato A, Mollica F, Meli C, Giovannini M, Riva E, Biasucci G, Henriksen KF, Güttler F: Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: Implications for diagnosis of hyperphenylalaninemia in southern Europe. Hum Mol Genet 1993;2: 1703-1707.
18. Guldberg P, Levy HL, Hanley WB, Koch R, Matalon R, Rouse BM, Trefz F, de la Cruz F, Henriksen KF, Güttler F: Phenylalanine hydroxylase gene mutations in the United States. Report from the Maternal PKU Collaborative Study. Am J Hum Genet 1996;59:84-94.
19. Hoppe BL, Conti Tronconi BM, Horton RM: Gel-loading dyes compatible with PCR. Biotechniques 1992;12:679-680.
20. Zschocke J, Graham CA, McKnight JJ, Nevin NC: The STR system in the human phenylalanine hydroxylase gene: True fragment length obtained with fluorescent labelled PCR primers. Acta Paediatr Suppl 1994;407:41-42.
21. Bjarnason O, Bjarnason V, Edwards JH, Fridrikson S, Magnusson M, Mourant AE, Tills D: The blood groups of Icelanders. Ann Hum Genet 1973;36:425-455.
22. Wijsman EM: Techniques for estimating genetic admixture and applications to the problem of the origin of the Icelanders and the Ashkenazi Jews. Hum Genet 1984;67:441-448.
23. Adalsteinsson S: Possible changes in the frequency of the human ABO blood groups in Iceland due to smallpox epidemics selection. Ann Hum Genet 1985;49:275-281.
24. Zschocke J, Mallory JP, Eiken HG, Nevin NC: Phenylketonuria and the peoples of Northern Ireland. Hum Genet 1997;100:189-194.
25. Guldberg P, Henriksen KF, Güttler F: Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 1993; 17:141-146.
26. Zschoke J, Graham CA, Carson DJ, Nevin NC: Phenylketonuria mutation analysis in Northern Ireland: A rapid stepwise approach. Am J Hum Genet 1995;57:1311-1317.
27. Tyfield LA, Stephenson A, Cockburn F, Harvie A, Bidwell JL, Wood NA, Pilz DT, Harper P, Smith I: Sequence variation at the phenylalanine hydroxylase gene in the British Isles. Am J Hum Genet 1997;60:388-396.
28. Bickel H, Bachmann C, Reckers R, Brandt NJ, Clayton BE, Corrado G, Feingold HJ, Giardini O, Hammersen G, Schönberg D: Neonatal mass screening for metabolic disorders. Eur J Pediatr 1981;137:133-139.
29. Chen J, Sahota A, Laxdal T, Serine M, Bowman S, Cui C, Stambrook PJ, Tischfield JA: Identification of a single missense mutation in the adenine phosphoribosyltransferase (APRT) gene from five Icelandic patients and a British patient. Am J Hum Genet 1991;49:1306-1311.
30. Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjord JE: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-119.